Showing results (391-400 of 449) with videos related to

Sort By:
Pageof 45
Oncogene|July 17, 2012
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAsS Das, K Bryan, P G Buckley, et al.
Translational Oncology|December 24, 2019
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid TumorsNatalie Timme, Youjia Han, Shuai Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with NeuroblastomaMarco Lodrini, Josefine Graef, Theresa M Thole-Kliesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
International Journal of Cancer|July 16, 2019
Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease modelTheresa M Thole, Joern Toedling, Annika Sprüssel, et al.
Der Urologe. Ausg. A|November 20, 2019
[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology]K Höfner, C Hampel, R Kirschner-Hermanns, et al.
The Lancet. Oncology|July 6, 2017
From class waivers to precision medicine in paediatric oncologyAndrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Cancer Research Communications|January 6, 2025
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with NeuroblastomaJan F Hollander, Annabell Szymansky, Jasmin Wünschel, et al.
Bone Marrow Transplantation|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastomaSveva Castelli, Tim Flaadt, Franziska Schulze, et al.
Pageof 45